Barleriside A, an aryl hydrocarbon receptor antagonist, ameliorates podocyte injury through inhibiting oxidative stress and inflammation
Article in Frontiers in Pharmacology (August 2024)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
Article in Frontiers in Pharmacology (August 2024)
Article in The Journal of Steroid Biochemistry and Molecular Biology (July 2024)
Article in Metabolic Syndrome and Related Disorders (May 2024)